<DOC>
	<DOC>NCT01384539</DOC>
	<brief_summary>The purpose of this study is to determine whether nutritional (cholecalciferol) or active vitamin D (calcitriol)supplementation improves vascular endothelial function in patients with stage IIIB and IV chronic kidney disease with vitamin D insufficiency or deficiency. The investigators hypothesize that the use of calcitriol supplementation will result in improved vascular endothelial function as compared to cholecalciferol supplementation.</brief_summary>
	<brief_title>Vitamin D and Arterial Function in Patients With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Age â‰¥ 18 years Chronic kidney disease stage IIIB or IV by 4 parameter Modified Diet in Renal Diseases Formula (Estimated Glomerular Filtration Rate [GFR] 4415 ml/min/1.73m2) Vitamin D (D2 + D3) deficient, defined as serum 25(OH)D level &lt; 30 ng/mL Corrected serum calcium &lt; 10.2 mg/dL Serum phosphate &lt; 4.6 mg/dL Serum albumin &gt; 3.0 g/dL Body mass index &lt; 40 kg/m2 Ability to give informed consent Significant comorbid conditions that lead the investigator to conclude that life expectancy is less than 1 year Expected to undergo living related kidney transplant in next 6 months Pregnant, breastfeeding, or unwilling to use adequate birth control History of severe liver disease Nephrotic range proteinuria (&gt; 3.5 gm/day) Use of active vitamin D analogs within 30 days of randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>chronic kidney disease</keyword>
	<keyword>vitamin D deficiency</keyword>
</DOC>